NEW YORK – The nanoparticle-based protein enrichment space has been active in recent months with companies issuing lawsuits and new product releases as they jockey for advantage. Perhaps as important as the competition within the space, however, is the positioning of nanoparticle enrichment systems within the broader plasma proteomics landscape, with firms still working to convince researchers to give the technology a shot.